Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma

by Jessica Guenzle, Harue Akasaka, Katharina Joechle, Wilfried Reichardt, Aina Venkatasamy, Jens Hoeppner, Claus Hellerbrand, Stefan Fichtner-Feigl, Sven A. Lang
Published 2021-12-01

Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.

by Marco Dollinger, René Müller-Wille, Florian Zeman, Michael Haimerl, Christoph Niessen, Lukas P Beyer, Sven A Lang, Andreas Teufel, Christian Stroszczynski, Philipp Wiggermann
Published 2015-01-01

Correction: Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.

by Marco Dollinger, René Müller-Wille, Florian Zeman, Michael Haimerl, Christoph Niessen, Lukas P Beyer, Sven A Lang, Andreas Teufel, Christian Stroszczynski, Philipp Wiggermann
Published 2015-01-01

Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in...

by Thorsten O. Goetze, Wolf O. Bechstein, Ulli Simone Bankstahl, Tobias Keck, Alfred Königsrainer, Sven A. Lang, Claudia Pauligk, Pompiliu Piso, Arndt Vogel, Salah-Eddin Al-Batran
Published 2020-02-01

Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis

by Katharina M. Schmidt, Peter Dietrich, Christina Hackl, Jessica Guenzle, Peter Bronsert, Christine Wagner, Stefan Fichtner-Feigl, Hans J. Schlitt, Edward K. Geissler, Claus Hellerbrand, Sven A. Lang
Published 2018-12-01

STAT5b as Molecular Target in Pancreatic Cancer—Inhibition of Tumor Growth, Angiogenesis, and Metastases

by Christian Moser, Petra Ruemmele, Sebastian Gehmert, Hedwig Schenk, Marina P Kreutz, Maria E Mycielska, Christina Hackl, Alexander Kroemer, Andreas A Schnitzbauer, Oliver Stoeltzing, Hans J Schlitt, Edward K Geissler, Sven A Lang
Published 2012-10-01

New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells.

by Eva Gottfried, Sven A Lang, Kathrin Renner, Anja Bosserhoff, Wolfram Gronwald, Michael Rehli, Sabine Einhell, Isabel Gedig, Katrin Singer, Anton Seilbeck, Andreas Mackensen, Oliver Grauer, Peter Hau, Katja Dettmer, Reinhard Andreesen, Peter J Oefner, Marina Kreutz
Published 2013-01-01

Adaptive Subsets Limit the Anti-Tumoral NK-Cell Activity in Hepatocellular Carcinoma

by Charlotte Rennert, Catrin Tauber, Pia Fehrenbach, Kathrin Heim, Dominik Bettinger, Özlem Sogukpinar, Anita Schuch, Britta Franziska Zecher, Bertram Bengsch, Sven A. Lang, Peter Bronsert, Niklas K. Björkström, Stefan Fichtner-Feigl, Michael Schultheiss, Robert Thimme, Maike Hofmann
Published 2021-06-01

Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy

by Kathrin Renner, Christina Bruss, Annette Schnell, Gudrun Koehl, Holger M. Becker, Matthias Fante, Ayse-Nur Menevse, Nathalie Kauer, Raquel Blazquez, Lisa Hacker, Sonja-Maria Decking, Toszka Bohn, Stephanie Faerber, Katja Evert, Lisa Aigle, Sabine Amslinger, Maria Landa, Oscar Krijgsman, Elisa A. Rozeman, Christina Brummer, Peter J. Siska, Katrin Singer, Stefanie Pektor, Matthias Miederer, Katrin Peter, Eva Gottfried, Wolfgang Herr, Ibtisam Marchiq, Jacques Pouyssegur, William R. Roush, SuFey Ong, Sarah Warren, Tobias Pukrop, Philipp Beckhove, Sven A. Lang, Tobias Bopp, Christian U. Blank, John L. Cleveland, Peter J. Oefner, Katja Dettmer, Mark Selby, Marina Kreutz
Published 2019-10-01